Table 1.
donor ID no. | UCH-L1 protein (pmol/mg tissue protein)a
|
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
control
|
AD
|
|||||||||||||||||
1 | 5 | 9 | 12 | 13 | 14 | 15 | 18 | 2 | 3 | 6 | 7 | 8 | 10 | 11 | 16 | 17 | 19 | |
Supernatant | ||||||||||||||||||
Q1 consensus | 245 ± 10 | 185 ± 12 | 235 ± 3 | 253 ± 16 | 198 ± 8 224 ± 31 |
192 ± 5 | 214 ± 16 | 269 ± 18 | 181 ± 16 | 67 ± 13 | 211 ± 3 | 168 ± 2 | 83 ± 1 | 130 ± 7 131 ± 50 |
121 ± 19 | 121 ± 10 | 65 ± 6 | 165 ± 13 |
Q3 consensus | 342 ± 23 | 277 ± 18 | 387 ± 16 | 335 ± 13 | 280 ± 16 311 ± 63 |
183 ± 7 | 328 ± 3 | 354 ± 20 | 138 ± 20 | 76 ± 15 | 199 ± 21 | 233 ± 18 | 178 ± 6 | 164 ± 8 167 ± 56 |
162 ± 6 | 213 ± 15 | 77 ± 4 | 225 ± 11 |
Pellet | ||||||||||||||||||
Q1 consensus | 87 ± 2 | 83 ± 18 | 125 ± 4 | 81 ± 19 | 72 ± 6 90 ± 22 |
103 ± 9 | 57 ± 6 | 112 ± 17 | 62 ± 11 | 85 ± 12 | 113 ± 3 | 108 ± 10 | 110 ± 1 | 81 ± 4 102 ± 26 |
109 ± 11 | 100 ± 10 | 160 ± 4 | 94 ± 5 |
Q3 consensus | 117 ± 7 | 111 ± 12 | 105 ± 14 | 115 ± 12 | 140 ± 16 119 ± 28 |
175 ± 8 | 78 ± 8 | 113 ± 4 | 75 ± 7 | 118 ± 10 | 138 ± 18 | 141 ± 20 | 117 ± 5 | 154 ± 9 136 ± 36 |
183 ± 17 | 150 ± 14 | 191 ± 6 | 96 ± 10 |
Measurements were performed on frontal cortex high-speed supernatant and pellet from control and severe AD human donors (Supporting Information, Table S1). The concentration was calculated for three experimental replicates by monitoring three transitions per individual Q1 and Q3 peptides. For the consensus, the data based on Q1 or Q3 peptides were combined for each control and AD groups. All data are presented as mean ± SD. The monitored transitions are summarized in the Supporting Information, Table S2.